SCHEMBL25139350

SCHEMBL25139350

CC(C)CC(C)(C(=O)Oc1cccc2c(O)cccc12)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 13/20 0.46
▸ ESR2 Q92731 13/20 0.46
▸ KMT2A Q03164 6/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ GAA P10253 5/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ JAK2 O60674 1/20 0.46
▸ USP2 O75604 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ POLB P06746 2/20 0.44
▸ AAK1 Q2M2I8 2/20 0.36
▸ ELANE P08246 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CA12 O43570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11991240 0.82 ESR1 (0.51) ESR1ESR2KMT2AMEN1GAA
SCHEMBL18785883 0.78 ESR1 (0.57) ESR1ESR2KMT2AMEN1GAA
SCHEMBL15189295 0.77 ESR1 (0.49) ESR1ESR2KMT2AMEN1GAA
SCHEMBL22876775 0.77 ELANE (0.39) GAASMN1; SMN2MAPTNPSR1HSD17B10
SCHEMBL92373 0.76 ESR1 (0.51) ESR1ESR2KMT2AMEN1GAA
SCHEMBL18887952 0.76 ESR1 (0.54) ESR1ESR2KMT2AMEN1GAA
SCHEMBL20274282 0.75 ESR1 (0.52) ESR1ESR2KMT2AMEN1GAA
SCHEMBL18671983 0.74 ESR1 (0.49) ESR1ESR2KMT2AMEN1GAA
SCHEMBL14220068 0.74 ESR1 (0.49) ESR1ESR2KMT2AMEN1GAA
SCHEMBL11991239 0.73 ESR1 (0.44) ESR1ESR2KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230367212-A1 PATTERN FORMING METHOD AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2023-11-16 — — US disclosed
US-20230123203-A1 METHOD FOR PRODUCING ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, METHOD FOR PRODUCING ELECTRONIC DEVICE, AND METHOD FOR PRODUCING ONIUM SALT FUJIFILM CORPORATION (JP) 2023-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230123203-A1 METHOD FOR PRODUCING ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, METHOD FOR PRODUCING ELECTRONIC DEVICE, AND METHOD FOR PRODUCING ONIUM SALT PRKAR2B, GRK7, PRKAR2A ESR1 1387/4885ESR2 1468/4885KMT2A 2169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback